Research Topics
| S D RamseySummaryAffiliation: University of Washington Country: USA Publications
| Collaborators
|
Detail Information
Publications
Optimizing sampling strategies for estimating quality-adjusted life yearsS D Ramsey
Department of Medicine, University of Washington Medical Center, Seattle, USA
Med Decis Making 17:431-8. 1997..Such data are frequently available from disease registries, the literature, or previous studies...
Simulation modeling of outcomes and cost effectivenessS D Ramsey
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Hematol Oncol Clin North Am 14:925-38. 2000..The purpose of this article is to clarify the process of modeling, so that readers of models are more knowledgeable about their uses, strengths, and limitations...
Methods for reviewing economic evaluations of community preventive services: a cart without a horse?S D Ramsey
Department of Medicine, University of Washington, Seattle, USA
Am J Prev Med 18:15-7. 2000..In conclusion, the methods for systematic review of economic evaluations in the American Journal of Preventive Medicine are important steps. However, it is advisable to use caution in applying them...
Patient-level estimates of the cost of complications in diabetes in a managed-care populationS D Ramsey
Department of Medicine, University of Washington, Seattle, USA
Pharmacoeconomics 16:285-95. 1999..To develop incidence-based estimates of the cost of several diabetes-related complications...
The limited state of technology assessment for medical devices: facing the issuesS D Ramsey
Center for Cost and Outcomes Research, University of Washington, Seattle, WA 98103, USA
Am J Manag Care 4:SP188-99. 1998....
Economic evaluation of aquatic exercise for persons with osteoarthritisD L Patrick
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Med Care 39:413-24. 2001..To estimate cost and outcomes of the Arthritis Foundation aquatic exercise classes from the societal perspective...
Effect of improved glycemic control on health care costs and utilizationE H Wagner
MacColl Institute for Healthcare Innovation, Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Suite 1290, Seattle, WA 98101, USA
JAMA 285:182-9. 2001..Because of the additional costs associated with improving diabetes management, there is interest in whether improved glycemic control leads to reductions in health care costs, and, if so, when such cost savings occur...
On the use of survival analysis techniques to estimate medical care costsR D Etzioni
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Health Econ 18:365-80. 1999..Our observations are confirmed through simulations and empirical data analysis. We conclude that survival analysis approaches are not generally appropriate for the analysis of medical costs and review several valid alternatives...
Design issues for conducting cost-effectiveness analyses alongside clinical trialsS D Ramsey
Department of Medicine, University of Washington, Seattle, Washington 98195, USA
Annu Rev Public Health 22:129-41. 2001..Many potential threats to external validity can be successfully addressed if they are identified and accounted for in the design phase of the study...
The economic burden of COPDS D Sullivan
Departments of Pharmacy and Health Services, University of Washington, Seattle, WA 98195, USA
Chest 117:5S-9S. 2000..These trends reflect population aging, smoking patterns, institutional factors, and treatment practices...
Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancerS D Ramsey
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North MP 900, Box 19024, Seattle, WA 98109, USA
Ann Intern Med 135:577-88. 2001..The National Cancer Institute has published consensus guidelines for universal screening for hereditary nonpolyposis colorectal cancer (HNPCC) in patients with newly diagnosed colorectal cancer...
A comparison of approaches for association studies of polymorphisms and colorectal cancer riskS D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Colorectal Dis 14:e573-86. 2012..Our aim was to apply well-established quality-control criteria to individual association studies and then compare the results of meta-analyses that included or excluded studies that did not meet these criteria...
The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case studyR Etzioni
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Health Econ 10:245-56. 2001..The results emphasize the need to adopt a standard approach for dealing with future costs when evaluating lifesaving interventions for cost-effectiveness analyses...
Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996H F Huizenga
Division of General Internal Medicine and Health Services, University of Washington, Veterans Administration Puget Sound Health Care System, Seattle 98108, USA
Chest 114:1583-7. 1998..To estimate the number of lung volume reduction surgery procedures performed on Medicare enrollees from 1994 to 1996...
Effect of compensation method on the behavior of primary care physicians in managed care organizations: evidence from interviews with physicians and medical leaders in Washington StateB K Zierler
University of Washington, Seattle 98195 6410, USA
Am J Manag Care 4:209-20. 1998..The responses revealed in interviews with physicians and administrative leaders underscored the critical role compensation arrangements play in driving physician satisfaction and behavior...
Patterns of blood product use among patients with myelodysplastic syndromeS D Ramsey
Research and Economic Assessment in Cancer and Healthcare REACH Group, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Vox Sang 102:331-7. 2012....
Suboptimal medical therapy in COPD: exploring the causes and consequencesS D Ramsey
Departments of Medicine and Health Services, University of Washington, Seattle 98103, USA
Chest 117:33S-7S. 2000..Without such data, managed care organizations will be reluctant to allocate scarce resources toward expensive guideline implementation programs for individuals with this condition...
Relative impact of patient and clinic factors on adherence to primary care preventive service guidelines: an exploratory studyS D Ramsey
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Med Care 39:979-89. 2001..Preventive care service use is commonly compared across health plans, clinics, or individual providers, yet little is known about the influence of the clinic versus patient factors on utilization of these services...
Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research GroupS D Ramsey
Department of Medicine, University of Washington, Seattle, USA
Ann Thorac Surg 71:995-1002. 2001....
Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetesN Chaiyakunapruk
Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
J Cardiovasc Risk 8:127-32. 2001..Cost-effectiveness studies of statins in the diabetic population are detailed, along with recommendations for further research...
The burden of illness and economic evaluation for COPDS D Ramsey
Fred Hutchinson Cancer Research Center, Dept of Pharmacy, University of Washington, Seattle, WA 98109, USA
Eur Respir J Suppl 41:29s-35s. 2003....
Use of alternative therapies by older adults with osteoarthritisS D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Arthritis Rheum 45:222-7. 2001..CONCLUSION: Use of and expenditures for alternative care were high among this cohort of older adults with OA. Clinicians may want to inquire about use of these therapies before recommending treatments for this condition...
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle 98195, USA
Pharmacoeconomics 19:535-50. 2001..To determine the cost of using systemic therapy to treat newly diagnosed cytomegalovirus (CMV) retinitis in persons with AIDS...
